Breaking News Instant updates and real-time market news.

HSIC

Henry Schein

$60.38

1.26 (2.13%)

07:55
02/12/19
02/12
07:55
02/12/19
07:55

Henry Schein price target lowered to $69 from $85 at RBC Capital

RBC Capital analyst Stephen Hagan lowered his price target on Henry Schein to $69 to reflect his updated model after the company's animal health business spin-off. The analyst notes that the spin-off has made shares more attractive, but sees the 18-times forward earnings multiple assumed in his price target as a hurdle to a more positive rating on the shares. Hagan also keeps his Sector Perform rating on Henry Schein.

  • 20

    Feb

HSIC Henry Schein
$60.38

1.26 (2.13%)

01/02/19
01/02/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Henry Schein (HSIC) downgraded to Neutral from Outperform at Baird with analyst Jeff Johnson saying he is more cautious on the combination of the dental sector's secular overhangs, softer Q4 patient volume checks, and accelerating equipment pricing pressures. 2. Conagra Brands (CAG) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Jason English saying while the stock's 41% decline since October 23 is overdone, the "path of recovery is likely to be protracted." 3. BioMarin (BMRN) downgraded to Market Perform from Outperform at Raymond James with analyst Laura Chico saying BioMarin lacks near-term catalysts which makes it more vulnerable in a "risk off" environment. 4. Hologic (HOLX) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst David Lewis saying his checks with about 40 medspas highlighted market saturation of body sculpting devices. 5. Louisiana-Pacific (LPX) downgraded to Neutral from Buy at BofA/Merrill with analyst George Staphos citing the steep drop-off in 2H 2018 panel pricing and challenging 1H 2019 comparisons versus 1H 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/19
EVER
01/03/19
DOWNGRADE
EVER
Underperform
Henry Schein downgraded to Underperform from In Line at Evercore ISI
01/03/19
EVER
01/03/19
DOWNGRADE
EVER
Underperform
Henry Schein downgraded to Underperform at Evercore ISI
As previously reported, Evercore ISI downgraded Henry Schein to Underperform from In Line. Analyst Ross Muken remains negative on the Dental complex given long-term risks to margins due to pricing, competition, and disintermediation. Muken expects a moderation in the company's share gains in consumables/high-tech equipment, and said the CVET spin is near completion with underling profit likely lower short-term.
01/17/19
UBSW
01/17/19
INITIATION
Target $73
UBSW
Sell
Henry Schein initiated with a Sell at UBS
UBS analyst Kevin Caliendo started Henry Schein with a Sell rating and $73 price target. The analyst's long-term EBIT and earnings estimates are below consensus as he expects ongoing margin pressures to offset Henry Schein's cost saving initiatives and partnership synergies.

TODAY'S FREE FLY STORIES

STMP

Stamps.com

$198.08

-4.03 (-1.99%)

08:11
02/22/19
02/22
08:11
02/22/19
08:11
Downgrade
Stamps.com rating change  »

Stamps.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$36.03

2.6 (7.78%)

08:11
02/22/19
02/22
08:11
02/22/19
08:11
Downgrade
Kirkland Lake Gold rating change  »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CMRX

Chimerix

$1.92

-0.04 (-2.04%)

08:10
02/22/19
02/22
08:10
02/22/19
08:10
Hot Stocks
Chimerix presents results from Phase 3 SUPPRESS trial »

Chimerix announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDOC

Teladoc

$68.25

-1.25 (-1.80%)

08:09
02/22/19
02/22
08:09
02/22/19
08:09
Recommendations
Teladoc analyst commentary  »

Teladoc view remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CLSH

CLS Holdings

08:08
02/22/19
02/22
08:08
02/22/19
08:08
Initiation
CLS Holdings initiated  »

CLS Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

$59.50

-15.62 (-20.79%)

08:08
02/22/19
02/22
08:08
02/22/19
08:08
Upgrade
ATN International rating change  »

ATN International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 28

    Mar

MDRX

Allscripts

$11.93

-0.21 (-1.73%)

08:07
02/22/19
02/22
08:07
02/22/19
08:07
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$35.55

-0.26 (-0.73%)

08:07
02/22/19
02/22
08:07
02/22/19
08:07
Hot Stocks
Veritiv to optimize wide format products business »

Veritiv announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

08:06
02/22/19
02/22
08:06
02/22/19
08:06
Recommendations
Appian analyst commentary  »

Appian getting closer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

K

Kellogg

$58.33

-0.13 (-0.22%)

08:06
02/22/19
02/22
08:06
02/22/19
08:06
Hot Stocks
Kellogg elects Erica Mann, Roderick Gillum to board »

Kellogg announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

SYNL

Synalloy

$12.94

0.11 (0.86%)

08:05
02/22/19
02/22
08:05
02/22/19
08:05
Hot Stocks
Synalloy announces stock repurchase program for up to 850,000 shares »

Synalloy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIDU

Baidu

$171.72

0.64 (0.37%)

08:05
02/22/19
02/22
08:05
02/22/19
08:05
Recommendations
Baidu analyst commentary  »

Baidu price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MYL

Mylan

$31.06

-0.54 (-1.71%)

08:04
02/22/19
02/22
08:04
02/22/19
08:04
Hot Stocks
Mylan announces U.S. launch of generic Suboxone Sublingual Film »

Mylan announced the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Earnings
Obalon Therapeutics reports Q4 EPS (39c), consensus (36c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

TTD

Trade Desk

$150.18

0.07 (0.05%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

HTH

Hilltop Holdings

$19.63

0.06 (0.31%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Hot Stocks
Hilltop Holdings announces retirement of co-CEO Alan White »

Hilltop Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$78.76

-1.26 (-1.57%)

, VYGR

Voyager Therapeutics

$10.70

-0.19 (-1.74%)

08:02
02/22/19
02/22
08:02
02/22/19
08:02
Hot Stocks
AbbVie, Voyager Therapeutics partner to develop vectorized antibodies »

AbbVie (ABBV) and Voyager…

ABBV

AbbVie

$78.76

-1.26 (-1.57%)

VYGR

Voyager Therapeutics

$10.70

-0.19 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

  • 18

    May

VNTR

Venator Materials

$6.40

0.115 (1.83%)

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Initiation
Venator Materials initiated  »

Venator Materials resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Recommendations
Kraft Heinz analyst commentary  »

Kraft Heinz price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCS

Marcus

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Recommendations
Marcus analyst commentary  »

Marcus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

NE

Noble Corp.

$3.12

-0.2 (-6.02%)

08:00
02/22/19
02/22
08:00
02/22/19
08:00
Downgrade
Noble Corp. rating change  »

Noble Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

SO

Southern Company

$50.22

0.48 (0.97%)

07:59
02/22/19
02/22
07:59
02/22/19
07:59
Upgrade
Southern Company rating change  »

Southern Company upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDRX

Allscripts

$11.93

-0.21 (-1.73%)

07:59
02/22/19
02/22
07:59
02/22/19
07:59
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$70.50

0.23 (0.33%)

07:58
02/22/19
02/22
07:58
02/22/19
07:58
Downgrade
Eversource rating change  »

Eversource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

KEYS

Keysight Technologies

$81.74

0.67 (0.83%)

07:56
02/22/19
02/22
07:56
02/22/19
07:56
Recommendations
Keysight Technologies analyst commentary  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.